Ignite Creation Date:
2024-05-06 @ 3:03 PM
Last Modification Date:
2024-10-26 @ 1:41 PM
Study NCT ID:
NCT04502394
Status:
UNKNOWN
Last Update Posted:
2022-08-04
First Post:
2020-07-27
Brief Title:
Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With RR DLBCL or RR CLL
Sponsor:
Kartos Therapeutics Inc
Organization:
Kartos Therapeutics Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Non Hodgkin Lymphoma |
| Diffuse Large B Cell Lymphoma |
| Chronic Lymphocytic Leukemia |
Keywords:
| Name | View |
|---|---|
| navtemadlin | View |